Assertio Holdings, Inc. (ASRT)
23.44
+0.03
(+0.13%)
USD |
NASDAQ |
May 28, 16:00
23.39
-0.05
(-0.21%)
After-Hours: 19:08
Assertio Holdings Research and Development Expense (Annual) : 1.69M for Dec. 31, 2025
Research and Development Expense (Annual) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Annual) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (Annual) Benchmarks
| ANI Pharmaceuticals, Inc. | 51.66M |
| Corcept Therapeutics, Inc. | 254.91M |
| Merck & Co., Inc. | 12.51B |
| Lipocine, Inc. | 8.523M |
| Theravance Biopharma, Inc. | 35.91M |